Conversely, the IMQ-induced psoriasis paradigm primarily stimulates the IL-1 and TLR7 pathways, which, while contributing to inflammation, vary from the main IL-23/Th17-mediated inflammation reported in patients [55,56]. Here, IL1B is linked to psoriasis.